Partnerships

– Clinical Research Collaborations
– In-Licensing
– Companion Diagnostics
– Third Party Testing

MolecularMD has a unique combination of clinical oncology experience, assay development expertise and diagnostic manufacturing capability. This enables us to provide our pharmaceutical partners with a complete solution to the development of companion diagnostics.

We have extensive experience managing regulatory approvals and are able to provide our partners with support toward the adoption of new molecular diagnostic tests in the clinic.  In fact, MolecularMD has successfully launched and distributed companion diagnostic kits on an international scale.

Please contact our Business Development professionals to discuss collaborative or partnering opportunities.